EAGB has moved to the Silo Point building in Locust Point! Please be sure to update your records with our new address.
1200 Steuart St, Suite C1B Baltimore, MD 21230
Our completely new site is up and running! Thank you for your patience as we rebooted.
WorkSource Montgomery has grown exponentially in its first year, and we are happy to have new staff, a new address to our corporate headquarters and the opportunity to serve our businesses and talent each day. To celebrate a year of accomplishments, let’s take a look back at where we started.
In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup.
Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.
The European Commission approved Tecentriq, also known as atezolizumab, as a monotherapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) after patients have been treated with chemotherapy.
The market opportunity in health care is huge, and Apple sees health care and wellness as a core part of its app, services, and wearables strategies. Now the company is aiming to become your personal health record, jumping into research, medical devices, and more.
Startups and entrepreneurs involved with Johns Hopkins Technology Ventures secured hundreds of patents and invention disclosures, and brought in millions of dollars in funding in fiscal year 2017.
Please join the BioPark’s Monthly Networking Event. Mingle with BioPark tenants, and UMB faculty and staff.
Host: UM BioPark & Wexford Science + Technology
Location: UM BioPark On the Patio (weather permitting) 801 W. Baltimore Street Baltimore Maryland 21201
Time: September 27, 2017, 5:00pm to 6:30pm
An Annapolis medical technology company is moving its headquarters to The LaunchPort, a device manufacturing accelerator set to be housed at the City Garage startup hub in Port Covington.
Vixiar Medical spun out of research at Johns Hopkins. Three years later, the startup will officially be a Baltimore company.
Contrary Capital, a university-focused venture capital fund, officially launched on Monday at 55 colleges across the country, including Hopkins. Contrary works with 100 students to find start-ups and projects within their university communities in which they can invest.
